Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD

Name: Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD
License: Public Domain

Assiut University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

chronic kidney diseases, diabetes type 2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 172495
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.